Study: Sugary sodas and juices linked to higher cancer risk. Here's what you need to know
Friday, 12 July 2019
The new study found that drinking a small glass of juice or soda a day led to an increase in overall cancer risk.
Credit: CBS Dallas Digital - Published
on July 11, 2019 < > Embed
There's more bad news for fans of sugary drinks such as soda and fruit juice. Katie Johnston reports. A Small Glass Of Juice Or Soda A Day Is Linked To Increased Risk Of Cancer, Study Finds 00:32
You Might Like
Recent related videos from verified sources
Some protected bike lanes leave cyclists vulnerable to injury
Bike lanes separated from the roadway by physical barriers make cyclists feel safer and encourage more people to ride. But a new IIHS study shows that protected bike lanes vary in terms of injury risk...
Credit: MultiVu Duration: 01:35 Published 5 days ago
Eating Flavonoids Can Reduce Risk of Cancer: Study
A New study shows that eating and drinking flavonoid rich foods like fruits, vegetables, dark chocolate, tea, and red wine can help reduce your risk of cancer and heart disease.
Credit: Veuer Duration: 01:01 Published 6 days ago
These 5 Things Are Almost as Deadly as Smoking
These 5 Things
Are Almost as
Deadly as Smoking Despite the efforts of people ditching
smoking and getting healthier, other
bad habits are taking its place. 1. Loneliness According to Julianne..
Credit: Wibbitz Top Stories Duration: 01:44 Published 3 weeks ago
Recent related news from verified sources
More cancer cases among women with sleep apnea Women with severe sleep apnea appear to be at an elevated risk of getting cancer, a study shows. No causal relationship is demonstrated, but the link between... Science Daily 5 days ago
Aspirin may help some breast cancer survivors, but changes in DNA may mean harm for others Previous studies have shown that while some women who use aspirin and are later diagnosed with breast cancer may live longer, a portion of aspirin users with... Science Daily 1 week ago New Publication Shows Different Result of Risk Classification between GenesWell BCT and Oncotype DX in Breast Cancer Patients 50 Years Old or Younger. SEOUL, South Korea, Aug. 12, 2019 /PRNewswire/ -- Gencurix, Inc., a company dedicated in development and market of innovative molecular diagnostics, announced... PR Newswire Asia 1 week ago Other recent news in World